Source: International Congress 2017 – New insights into pathogenesis of lung disease 



Rating:

Share or cite this content

Citations should be made in the following way:
S. Orgeig (Adelaide, SA, Australia). Changes in lipid metabolism in mucopolysaccharidosis (MPS) IIIA mouse lung tissue and pulmonary surfactant. 2029

Member's Comments

No comment yet.

Related content which might interest you: Collagen I, III and IV content in airways and lung parenchyma of COPD patients Source: Annual Congress 2010 - Proteases and the matrix Year: 2010 Increased urotensin II in BALF and lung tissue in rat model of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 216s Year: 2006 Cellular origin of pro-coagulant and (anti)-fibrinolytic factors in bleomycin-injured lungs Source: Eur Respir J 2007; 29: 1105-1114 Year: 2007 Complex restrictive pulmonary function pattern in connective tissue disorders (CTD) with interstitial lung disease (ILD) Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications Year: 2019 Collagen type III content in large airways and distal lung of fatal asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005 Collagen content in human pulmonary emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 250s Year: 2001 Scleroderma lung disease: A scleroderma physiologic index (SPI) derived from lung physiology and oxygen saturation Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Transplant of alveolar type II cells restore pulmonary surfactant in lung fibrosis Source: Annual Congress 2010 - Stem cells and growth factors in lung injury Year: 2010 Decreased VEGF concentration in lung tissue and vascular injury during ARDS Source: Eur Respir J 2005; 25: 139-146 Year: 2005 Abnormal collagen type V deposition in lung fibroblast is correlated with a worse pulmonary function in systemic sclerosis Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis Source: International Congress 2016 – Connective tissue disorders Year: 2016 Type V collagen induced pulmonary fibrosis in C57Bl/6mice Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Pulmonary function and exercise tolerance in glycogenosis type II (GSDII) Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases Year: 2011 Pertechnegas lung clearance in different forms of interstitial lung disease Source: Eur Respir J 2002; 19: 31-36 Year: 2002 Imbalance of glutathione metabolism in type II pneumocytes after NO2 induced acute and chronic lung injury Source: Eur Respir J 2004; 24: Suppl. 48, 108s Year: 2004 Modulation of surfactant metabolism in type II cells from injured lungs by TNF-α and IL-10 Source: Eur Respir J 2003; 22: Suppl. 45, 78s Year: 2003 Lipid serum profile and copper content in serum and pulmonary tissue in experimental pulmonary emphysema Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010 Aging decreases reversibility of pulmonary fibrosis by regulating PRDM16-related fatty acid metabolism in lung fibroblasts Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 Regulation, cell-specific expression and metabolism of factor VII activating protease (FSAP) in lungs from patients with acute respiratory distress syndrome (ARDS) and idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2006; 28: Suppl. 50, 823s Year: 2006 Defective surfactant biosynthesis and ultrastructural abnormalities of alveolar type 2 cells in pulmonary fibrosis of conditional Nedd4-2mice Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019